{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:59:11Z","timestamp":1791845951836,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T00:00:00Z","timestamp":1445644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T00:00:00Z","timestamp":1445644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL102033"],"award-info":[{"award-number":["HL102033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2 UM1 HL087366-06"],"award-info":[{"award-number":["2 UM1 HL087366-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00109-015-1356-1","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T18:35:47Z","timestamp":1445711747000},"page":"37-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia"],"prefix":"10.1007","volume":"94","author":[{"given":"Yan Fei","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Paul","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J","family":"Pepine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Katovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan K","family":"Raizada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,24]]},"reference":[{"issue":"4","key":"1356_CR1","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despr\u00e9s JP, Fullerton HJ, Howard VJ et al (2015) Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association. Circulation 131(4):e29\u2013e322","journal-title":"Circulation"},{"key":"1356_CR2","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1161\/01.CIR.92.10.3105","volume":"92","author":"F Pieruzzi","year":"1995","unstructured":"Pieruzzi F, Abassi ZA, Keiser HR (1995) Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation 92:3105\u20133112","journal-title":"Circulation"},{"key":"1356_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1161\/01.HYP.0000205833.89478.5b","volume":"47","author":"K Yamamoto","year":"2006","unstructured":"Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, Kaibe M, Tatara Y, Shiota A, Sugano S, Takeda S et al (2006) Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 47:718\u2013726","journal-title":"Hypertension"},{"key":"1356_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cvr\/cvr036","volume":"91","author":"S Bodiga","year":"2011","unstructured":"Bodiga S, Zhong JC, Wang W, Basu R, Lo J, Liu GC, Guo D, Holland SM, Scholey JW, Penninger JM et al (2011) Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. Cardiovasc Res 91:151\u2013161","journal-title":"Cardiovasc Res"},{"key":"1356_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/CIRCHEARTFAILURE.108.840124","volume":"2","author":"Z Kassiri","year":"2009","unstructured":"Kassiri Z, Zhong J, Guo D, Basu R, Wang X, Liu PP, Scholey JW, Penninger JM, Oudit GY (2009) Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circ Heart Fail 2:446\u2013455","journal-title":"Circ Heart Fail"},{"key":"1356_CR6","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1161\/HYPERTENSIONAHA.107.100693","volume":"51","author":"S Der Sarkissian","year":"2008","unstructured":"Der Sarkissian S, Grobe JL, Yuan L, Narielwala DR, Walter GA, Katovich MJ, Raizada MK (2008) Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 51:712\u2013718","journal-title":"Hypertension"},{"key":"1356_CR7","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1089\/hum.2009.160","volume":"21","author":"YX Zhao","year":"2010","unstructured":"Zhao YX, Yin HQ, Yu QT, Qiao Y, Dai HY, Zhang MX, Zhang L, Liu YF, Wang LC, de Liu S et al (2010) ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction. Hum Gene Ther 21:1545\u20131554","journal-title":"Hum Gene Ther"},{"key":"1356_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.113.01337","volume":"62","author":"Y Qi","year":"2013","unstructured":"Qi Y, Zhang J, Cole-Jeffrey CT, Shenoy V, Espejo A, Hanna M, Song C, Pepine CJ, Katovich MJ, Raizada MK (2013) Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension 62:746\u2013752","journal-title":"Hypertension"},{"key":"1356_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1253\/circj.CJ-13-0013","volume":"77","author":"T Anzai","year":"2013","unstructured":"Anzai T (2013) Post-infarction inflammation and left ventricular remodeling: a double-edged sword. Circ J 77:580\u2013587","journal-title":"Circ J"},{"key":"1356_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1161\/01.CIR.0000115516.54550.B1","volume":"109","author":"BD Johnson","year":"2004","unstructured":"Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Bairey Merz CN, Sopko G et al (2004) Serum amyloid a as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women\u2019s Ischemia Syndrome Evaluation (WISE). Circulation 109:726\u2013732","journal-title":"Circulation"},{"key":"1356_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2174\/1871528113666140713164506","volume":"13","author":"RR Gaddam","year":"2014","unstructured":"Gaddam RR, Chambers S, Bhatia M (2014) ACE and ACE2 in inflammation: a tale of two enzymes. Inflamm Allergy Drug Targets 13:224\u2013234","journal-title":"Inflamm Allergy Drug Targets"},{"key":"1356_CR12","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111:2605\u20132610","journal-title":"Circulation"},{"key":"1356_CR13","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1113\/expphysiol.2011.056994","volume":"96","author":"Y Qi","year":"2011","unstructured":"Qi Y, Shenoy V, Wong F, Li H, Afzal A, Mocco J, Sumners C, Raizada MK, Katovich MJ (2011) Lentivirus-mediated overexpression of angiotensin-(1\u20137) attenuated ischaemia-induced cardiac pathophysiology. Exp Physiol 96:863\u2013874","journal-title":"Exp Physiol"},{"key":"1356_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3109\/08958378.2013.850563","volume":"26","author":"T Xue","year":"2014","unstructured":"Xue T, Wei N, Xin Z, Qingyu X (2014) Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease. Inhal Toxicol 26:14\u201322","journal-title":"Inhal Toxicol"},{"key":"1356_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","volume":"169","author":"AC Sim\u00f5es e Silva","year":"2013","unstructured":"Sim\u00f5es e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM (2013) ACE2, angiotensin-(1\u20137) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol 169:477\u2013492","journal-title":"Br J Pharmacol"},{"key":"1356_CR16","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","volume":"43","author":"Y Ishiyama","year":"2004","unstructured":"Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM (2004) Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43:970\u2013976","journal-title":"Hypertension"},{"key":"1356_CR17","doi-asserted-by":"publisher","first-page":"18899","DOI":"10.3390\/ijms140918899","volume":"14","author":"K Kikuchi","year":"2013","unstructured":"Kikuchi K, Tancharoen S, Ito T, Morimoto-Yamashita Y, Miura N, Kawahara K, Maruyama I, Murai Y, Tanaka E (2013) Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1\/RAGE axis in prevention and acute treatment of stroke. Int J Mol Sci 14:18899\u201318924","journal-title":"Int J Mol Sci"},{"key":"1356_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/MAJ.0b013e31821f0552","volume":"343","author":"T Nakamura","year":"2012","unstructured":"Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Yamada S, Ueda Y, Koide H (2012) Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension. Am J Med Sci 343:46\u201351","journal-title":"Am J Med Sci"},{"key":"1356_CR19","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1161\/CIRCULATIONAHA.108.769331","volume":"117","author":"M Andrassy","year":"2008","unstructured":"Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK et al (2008) High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117:3216\u20133226","journal-title":"Circulation"},{"key":"1356_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2119\/2008-00034.Klune","volume":"14","author":"JR Klune","year":"2008","unstructured":"Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A (2008) HMGB1: endogenous danger signaling. Mol Med 14:476\u2013484","journal-title":"Mol Med"},{"key":"1356_CR21","doi-asserted-by":"crossref","first-page":"206039","DOI":"10.1155\/2013\/206039","volume":"2013","author":"JJ de Haan","year":"2013","unstructured":"de Haan JJ, Smeets MB, Pasterkamp G, Arslan F (2013) Danger signals in the initiation of the inflammatory response after myocardial infarction. Mediators Inflamm 2013:206039","journal-title":"Mediators Inflamm"},{"key":"1356_CR22","doi-asserted-by":"crossref","first-page":"253075","DOI":"10.1155\/2014\/253075","volume":"2014","author":"J Zhang","year":"2014","unstructured":"Zhang J, Song J, Xu J, Chen X, Yin P, Lv X, Wang X (2014) ERK1\/2-Egr-1 signaling pathway-mediated protective effects of electroacupuncture in a mouse model of myocardial ischemia-reperfusion. Evid Based Complement Alternat Med 2014:253075","journal-title":"Evid Based Complement Alternat Med"},{"key":"1356_CR23","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1016\/j.ijcard.2013.04.121","volume":"168","author":"HD Theiss","year":"2013","unstructured":"Theiss HD, Gross L, Vallaster M, David R, Brunner S, Brenner C, Nathan P, Assmann G, Mueller-Hoecker J, Vogeser M et al (2013) Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction. Int J Cardiol 168:3359\u20133369","journal-title":"Int J Cardiol"},{"key":"1356_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.106.635664","volume":"114","author":"S Goser","year":"2006","unstructured":"Goser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, Zittrich S, Blaudeck N, Hardt SE, Pfitzer G et al (2006) Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 114:1693\u20131702","journal-title":"Circulation"},{"key":"1356_CR25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0022-2828(03)00177-9","volume":"35","author":"M Donoghue","year":"2003","unstructured":"Donoghue M, Wakimoto H, Maguire CT, Acton S, Hales P, Stagliano N, Fairchild-Huntress V, Xu J, Lorenz JN, Kadambi V et al (2003) Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J Mol Cell Cardiol 35:1043\u20131053","journal-title":"J Mol Cell Cardiol"},{"key":"1356_CR26","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3892\/etm.2015.2290","volume":"9","author":"Y Lin","year":"2015","unstructured":"Lin Y, Chen L, Li W, Fang J (2015) Role of high-mobility group box-1 in myocardial ischemia\/reperfusion injury and the effect of ethyl pyruvate. Exp Ther Med 9:1537\u20131541","journal-title":"Exp Ther Med"},{"key":"1356_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cvr\/cvn291","volume":"81","author":"T Kohno","year":"2009","unstructured":"Kohno T, Anzai T, Naito K, Miyasho T, Okamoto M, Yokota H, Yamada S, Maekawa Y, Takahashi T, Yoshikawa T et al (2009) Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc Res 81:565\u2013573","journal-title":"Cardiovasc Res"},{"key":"1356_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.shk.0000209540.99176.72","volume":"25","author":"RS Goldstein","year":"2006","unstructured":"Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, Lee DC, Ward MF, Bruchfeld AN, Wang H et al (2006) Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 25:571\u2013574","journal-title":"Shock"},{"key":"1356_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cardfail.2008.11.010","volume":"15","author":"P Cirillo","year":"2009","unstructured":"Cirillo P, Giallauria F, Pacileo M, Petrillo G, D'Agostino M, Vigorito C, Chiariello M (2009) Increased high mobility group box-1 protein levels are associated with impaired cardiopulmonary and echocardiographic findings after acute myocardial infarction. J Card Fail 15:362\u2013367","journal-title":"J Card Fail"},{"key":"1356_CR30","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1253\/circj.72.1012","volume":"72","author":"S Hagiwara","year":"2008","unstructured":"Hagiwara S, Iwasaka H, Uchino T, Noguchi T (2008) High mobility group box 1 induces a negative inotropic effect on the left ventricle in an isolated rat heart model of septic shock: a pilot study. Circ J 72:1012\u20131017","journal-title":"Circ J"},{"key":"1356_CR31","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jtcvs.2003.11.032","volume":"127","author":"YJ Woo","year":"2004","unstructured":"Woo YJ, Taylor MD, Cohen JE, Jayasankar V, Bish LT, Burdick J, Pirolli TJ, Berry MF, Hsu V, Grand T (2004) Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. J Thorac Cardiovasc Surg 127:1262\u20131269","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1356_CR32","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1161\/01.CIR.0000013847.07035.B9","volume":"105","author":"AE Loot","year":"2002","unstructured":"Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, Boomsma F, van Gilst WH (2002) Angiotensin-(1\u20137) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105:1548\u20131550","journal-title":"Circulation"},{"key":"1356_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/01.HYP.38.3.665","volume":"38","author":"AJ Ferreira","year":"2001","unstructured":"Ferreira AJ, Santos RA, Almeida AP (2001) Angiotensin-(1\u20137): cardioprotective effect in myocardial ischemia\/reperfusion. Hypertension 38:665\u2013668","journal-title":"Hypertension"},{"key":"1356_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3317\/jraas.2004.041","volume":"5","author":"WC De Mello","year":"2004","unstructured":"De Mello WC (2004) Angiotensin (1\u20137) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion. The role of the sodium pump. J Renin Angiotensin Aldosterone Syst 5:203\u2013208","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1356_CR35","doi-asserted-by":"publisher","first-page":"H1985","DOI":"10.1152\/ajpheart.01145.2002","volume":"284","author":"WO Sampaio","year":"2003","unstructured":"Sampaio WO, Nascimento AA, Santos RA (2003) Systemic and regional hemodynamic effects of angiotensin-(1\u20137) in rats. Am J Physiol Heart Circ Physiol 284:H1985\u2013H1994","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1356_CR36","doi-asserted-by":"publisher","first-page":"39721","DOI":"10.1074\/jbc.M105253200","volume":"276","author":"S AbdAlla","year":"2001","unstructured":"AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276:39721\u201339726","journal-title":"J Biol Chem"},{"key":"1356_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1161\/HYPERTENSIONAHA.111.180158","volume":"59","author":"A Rehman","year":"2011","unstructured":"Rehman A, Leibowitz A, Yamamoto N, Rautureau Y, Paradis P, Schiffrin EL (2011) Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension 59:291\u2013299","journal-title":"Hypertension"},{"key":"1356_CR38","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.108.784868","volume":"118","author":"E Kaschina","year":"2008","unstructured":"Kaschina E, Grzesiak A, Li J, Foryst-Ludwig A, Timm M, Rompe F, Sommerfeld M, Kemnitz UR, Curato C, Namsolleck P et al (2008) Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction? Circulation 118:2523\u20132532","journal-title":"Circulation"},{"key":"1356_CR39","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1161\/HYPERTENSIONAHA.113.02522","volume":"63","author":"D Lauer","year":"2014","unstructured":"Lauer D, Slavic S, Sommerfeld M, Thone-Reineke C, Sharkovska Y, Hallberg A, Dahlof B, Kintscher U, Unger T, Steckelings UM et al (2014) Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1\/matrix metalloproteinase 9 axis and transforming growth factor beta1 in the rat heart. Hypertension 63:e60\u2013e67","journal-title":"Hypertension"},{"key":"1356_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/cvr\/cvr242","volume":"92","author":"S Sriramula","year":"2011","unstructured":"Sriramula S, Cardinale JP, Lazartigues E, Francis J (2011) ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res 92:401\u2013408","journal-title":"Cardiovasc Res"},{"key":"1356_CR41","unstructured":"Zhu L, Carretero OA, Xu J, Harding P, Ramadurai N, Gu X, Peterson EL, Yang XP (2015) Activation of angiotensin II type 2 receptor suppresses TNF-\u03b1-induced ICAM-1 via NF-\u03baB: possible role of ACE2. Am J Physiol Heart Circ Physiol:ajpheart.00814.2014."},{"key":"1356_CR42","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ki.2013.193","volume":"84","author":"Q Ali","year":"2013","unstructured":"Ali Q, Wu Y, Hussain T (2013) Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats. Kidney Int 84:931\u2013939","journal-title":"Kidney Int"},{"key":"1356_CR43","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1161\/01.HYP.0000175813.04375.8a","volume":"46","author":"CH Castro","year":"2005","unstructured":"Castro CH, Santos RA, Ferreira AJ, Bader M, Alenina N, Almeida AP (2005) Evidence for a functional interaction of the angiotensin-(1\u20137) receptor Mas with AT1 and AT2 receptors in the mouse heart. Hypertension 46:937\u2013942","journal-title":"Hypertension"},{"key":"1356_CR44","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1111\/bph.13044","volume":"172","author":"E Bruce","year":"2015","unstructured":"Bruce E, Shenoy V, Rathinasabapathy A, Espejo A, Horowitz A, Oswalt A, Francis J, Nair A, Unger T, Raizada MK et al (2015) Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. Br J Pharmacol 172:2219\u20132231","journal-title":"Br J Pharmacol"},{"key":"1356_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11897-013-0178-0","volume":"11","author":"MA Chamsi-Pasha","year":"2014","unstructured":"Chamsi-Pasha MA, Shao Z, Tang WH (2014) Angiotensin-converting enzyme 2 as a therapeutic target for heart failure. Curr Heart Fail Rep 11:58\u201363","journal-title":"Curr Heart Fail Rep"},{"key":"1356_CR46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijcard.2014.01.011","volume":"172","author":"WK Wang","year":"2014","unstructured":"Wang WK, Wang B, Lu QH, Zhang W, Qin WD, Liu XJ, Liu XQ, An FS, Zhang Y, Zhang MX (2014) Inhibition of high-mobility group box 1 improves myocardial fibrosis and dysfunction in diabetic cardiomyopathy. Int J Cardiol 172:202\u2013212","journal-title":"Int J Cardiol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-015-1356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-015-1356-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-015-1356-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-015-1356-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T23:54:07Z","timestamp":1748649247000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-015-1356-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,24]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1007\/s00109-015-1356-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725879184.793521464","asserted-by":"object"}]},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,24]]},"assertion":[{"value":"19 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}